blindness from glp-1 NAION Vision Loss Lawsuit Doctor Explains GLP 1 Blindness

Why does receptor biology matter for drug discovery

DHVR has acted as a consultant for AstraZeneca, Bayer, Boehringer Ingelheim, Eli Lilly, Merck, and Novo Nordisk and has received research funding from AstraZeneca, Boehringer Ingelheim, Eli Lilly, Merck, and Novo Nordisk

GLP-1 Clinical Practice Updates: August 2025 Key Developments August 2025 delivered significant clinical practice updates that advance the GLP-1 treatment landscape, including the first generic approval, expanded FDA indications, and major oral therapy breakthroughs

This cooperation is the most recent in a series of efforts to collaborate across the ecosystem and employ multimodal data to increase our understanding of biology

While some are optimistic that it will expand access to GLP-1 drugs for weight loss, others doubt the Trump administration will be able to negotiate lower prices than the insurance companies approved to offer Medicare Part D plans can and question how many state Medicaid agencies will choose to participate, given the long-term budget exposure associated with chronic use of high-cost drugs

What stood out to me is how complex yet structured the downstream process can be from cell culture and fusion protein purification, all the way to reverse phase chromatography and high-pressure purification